Medical University Pleven, University Hospital Saint Marina-Pleven, Pleven, 5800, Bulgaria.
Gynecologic Oncology Program, AdventHealth Cancer Institute, FSU and UCF Colleges of Medicine, 2501 N. Orange Ave., Suite 786, Orlando, FL, 32804, USA.
J Robot Surg. 2022 Apr;16(2):339-352. doi: 10.1007/s11701-021-01244-1. Epub 2021 Apr 28.
To assess and compare the peri-operative, oncologic, and survival outcomes for women with cervical cancer (CC) treated with abdominal radical hysterectomy (ARH) versus robotic radical hysterectomy (RRH) approaches in Bulgaria. We retrospectively analyzed patients with histologically diagnosed CC operated via ARH or RRH methods during January-2008 to April-2019. The data analyzed include patients and tumor characteristics, peri-operative outcomes, and disease status. Kaplan-Meier method and Cox regression analysis were performed to determine disease-free survival (DFS) and overall survival (OS). There were consecutive 1347 patients (ARH = 1006, RRH = 341), which formed the basis of study analyses. Women in the RRH group had significantly shorter median hospital length-of-stay than ARH cases (7 vs. 11 days, p < 0.001), higher post-operative hemoglobin (116 vs. 108 g/L, p < 0.001), and fewer blood transfusions (7.3% vs. 21.5%, p < 0.001), respectively. The overall incidence of post-operative complications was also lower in the RRH vs. ARH group (2.1% vs. 9.4%, p < 0.001). Median follow-up time for ARH vs. RRH groups was 4.32 vs. 5.24 years, respectively (p < 0.001). Kaplan-Meier analysis demonstrated that the RRH cohort had a significantly higher survival rate compared to the ARH group (CC-specific death 8.5% vs. 16.5% respectively). Mean time to recurrence did not differ significantly in either surgical approach (p = 0.495). Cox multivariate regression showed no significant impact of surgical approach on DFS or OS. No significant difference in DFS or OS between ARH vs. RRH for CC was observed. RRH approach does not lead to inferior oncologic outcomes and is associated with better peri-operative outcomes. In regard to "all stages" of CC, we found robotic surgery safer compared to laparotomy, and thus consider RRH a better surgical treatment option for patients with CC.
评估和比较保加利亚接受腹式根治性子宫切除术(ARH)与机器人根治性子宫切除术(RRH)治疗宫颈癌(CC)的围手术期、肿瘤学和生存结局。我们回顾性分析了 2008 年 1 月至 2019 年 4 月期间接受 ARH 或 RRH 方法治疗的组织学诊断为 CC 的患者。分析的数据包括患者和肿瘤特征、围手术期结果和疾病状况。采用 Kaplan-Meier 法和 Cox 回归分析确定无病生存(DFS)和总生存(OS)。共有 1347 例连续患者(ARH=1006 例,RRH=341 例),作为研究分析的基础。RRH 组的女性中位住院时间明显短于 ARH 组(7 天 vs. 11 天,p<0.001),术后血红蛋白(116 克/升 vs. 108 克/升,p<0.001)更高,输血更少(7.3% vs. 21.5%,p<0.001)。RRH 组的术后并发症总发生率也低于 ARH 组(2.1% vs. 9.4%,p<0.001)。ARH 组和 RRH 组的中位随访时间分别为 4.32 年和 5.24 年(p<0.001)。Kaplan-Meier 分析表明,RRH 组的生存率明显高于 ARH 组(CC 特异性死亡分别为 8.5%和 16.5%)。两种手术方式的复发中位时间无显著差异(p=0.495)。Cox 多变量回归显示手术方式对 DFS 或 OS 无显著影响。ARH 组与 RRH 组在 CC 的 DFS 或 OS 无显著差异。RRH 方法不会导致肿瘤学结果恶化,并且与更好的围手术期结果相关。关于 CC 的“所有阶段”,我们发现与剖腹手术相比,机器人手术更安全,因此认为 RRH 是 CC 患者更好的手术治疗选择。